Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Changes of Cognitive Function in Patients With Mild to Moderate Alzheimer's Disease Associated With or Without White Matter Changes After Rivastigmine Patch Therapy - Multi-center, Prospective, Open-label Clinical Trial

NCT01380288 is registered in ClinicalTrials.gov with Dong-A University as lead sponsor.

NCT NCT01380288
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01380288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Changes of Cognitive Function in Patients With Mild to Moderate Alzheimer's Disease Associated With or Without White Matter Changes After Rivastigmine Patch Therapy - Multi-center, Prospective, Open-label Clinical Trial
Lead sponsor
Dong-A University
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2011
Completion date
December 31, 2017
Enrollment
300 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease